"FDA"^^ . "C61072"^^ . "epothilone ZK219477PTNCI-GLOSSCDR0000537170" . "SAGOPILONEPTFDAKY72JU32FO" . "Sagopilone"^^ . "C30H41NO6S"^^ . "C2355512"^^ . "A fully synthetic low-molecular-weight epothilone with potential antineoplastic activity. Sagopilone binds to tubulin and induces microtubule polymerization while stabilizing microtubules against depolymerization, which may result in the inhibition of cell division, the induction of G2/M arrest, and apoptosis. The agent is not a substrate for the P-glycoprotein (P-gp) efflux pump and so may exhibit activity in multidrug-resistant (MDR) tumors. The epothilone class of metabolites was originally isolated from the myxobacterium Solangium cellulosum.NCI" . "Pharmacologic Substance"^^ . "A form of the substance epothilone that is made in the laboratory. It is being studied in the treatment of some types of cancer. Epothilone ZK2219477 stops the growth of tumor cells by blocking cell division. It is a type of antimitotic agent.NCI-GLOSS" . "ZK219477"^^ . . "KY72JU32FO"^^ . "615854"^^ . "DE-03757CNNCI" . "SagopilonePTNCI" . "Epothilone ZK219477SYNCI" . . "ZK-EPOABNCI" . "615854"^^ . "305841-29-6"^^ . "(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,12,16-tetramethyl-3-(2-methyl-1,3-benzothiazol-5-yl)-10-(prop-2-enyl)-4,17-dioxabicyclo(14.1.0)heptadecane-5,9-dioneSNNCI" . "ZK-EpothiloneSYNCI" . "ZK-219477CNNCI" . . . "SH-Y03757ACNNCI" . "Chemical Viewed Structurally"^^ . . "Sagopilone"^^ .